| SC 13G/A | 2023-02-14 | Redmile Group, LLC | Annexon, Inc. | 4,897,575 | 9.9% | EDGAR |
| SC 13G/A | 2023-02-14 | Bain Capital Life Sciences Fund, L.P. | Annexon, Inc. | 4,886,616 | 10.0% | EDGAR |
| SC 13G/A | 2023-02-14 | ALLIANCEBERNSTEIN L.P. | Annexon, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | Annexon, Inc. | 3,626,508 | 7.6% | EDGAR |
| SC 13G/A | 2023-02-09 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Annexon, Inc. | 4,195,761 | 8.7% | EDGAR |
| SC 13G | 2023-02-03 | PICTET ASSET MANAGEMENT SA | Annexon, Inc. | 1,232,713 | 2.6% | EDGAR |
| SC 13G/A | 2023-02-01 | FEDERATED HERMES, INC. | Annexon, Inc. | 3,057,800 | 6.4% | EDGAR |
| SC 13D | 2022-07-18 | Satter Muneer A | Annexon, Inc. | 5,032,463 | 10.4% | EDGAR |
| SC 13G/A | 2022-07-18 | Redmile Group, LLC | Annexon, Inc. | 4,891,693 | 9.9% | EDGAR |
| SC 13G | 2022-07-18 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Annexon, Inc. | 4,184,561 | 8.7% | EDGAR |
| SC 13G | 2022-07-08 | BlackRock Inc. | Annexon, Inc. | 961,043 | 2.5% | EDGAR |
| SC 13G | 2022-06-23 | Venrock Healthcare Capital Partners II, L.P. | Annexon, Inc. | 1,928,477 | 5.0% | EDGAR |
| SC 13G | 2022-05-26 | BIOTECHNOLOGY VALUE FUND L P | Annexon, Inc. | 1,809,854 | 4.7% | EDGAR |
| SC 13G | 2022-04-21 | Fairmount Funds Management LLC | Annexon, Inc. | 2,569,400 | 6.7% | EDGAR |
| SC 13G/A | 2022-02-14 | CITADEL ADVISORS LLC | Annexon, Inc. | - | 3.8% | EDGAR |
| SC 13G/A | 2022-02-14 | Redmile Group, LLC | Annexon, Inc. | 3,228,917 | 8.4% | EDGAR |
| SC 13G/A | 2022-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | Annexon, Inc. | 2,850,000 | 7.4% | EDGAR |
| SC 13G | 2022-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Annexon, Inc. | 2,876,667 | 7.4% | EDGAR |
| SC 13G | 2022-02-14 | ALLIANCEBERNSTEIN L.P. | Annexon, Inc. | 2,090,355 | 5.4% | EDGAR |
| SC 13G | 2022-02-14 | FEDERATED HERMES, INC. | Annexon, Inc. | 2,025,600 | 5.3% | EDGAR |